China Pharma Holdings EPS - Earnings per Share 2010-2025 | CPHI
China Pharma Holdings eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| China Pharma Holdings Annual EPS |
| 2024 |
$-2.70 |
| 2023 |
$-9.10 |
| 2022 |
$-37.80 |
| 2021 |
$-37.00 |
| 2020 |
$-35.00 |
| 2019 |
$-240.00 |
| 2018 |
$-125.00 |
| 2017 |
$-220.00 |
| 2016 |
$-105.00 |
| 2015 |
$-175.00 |
| 2014 |
$-455.00 |
| 2013 |
$-230.00 |
| 2012 |
$55.00 |
| 2011 |
$220.00 |
| 2010 |
$270.00 |
| 2009 |
$215.00 |
| China Pharma Holdings Quarterly EPS |
| 2025-03-31 |
$-0.24 |
| 2024-12-31 |
$-0.48 |
| 2024-09-30 |
$-0.60 |
| 2024-06-30 |
$-0.90 |
| 2024-03-31 |
$-0.72 |
| 2023-12-31 |
$0.20 |
| 2023-09-30 |
$-2.90 |
| 2023-06-30 |
$-3.50 |
| 2023-03-31 |
$-2.90 |
| 2022-12-31 |
$-9.80 |
| 2022-09-30 |
$-8.00 |
| 2022-06-30 |
$-9.00 |
| 2022-03-31 |
$-11.00 |
| 2021-12-31 |
$-7.00 |
| 2021-09-30 |
$-10.00 |
| 2021-06-30 |
$-10.00 |
| 2021-03-31 |
$-10.00 |
| 2020-12-31 |
$-15.00 |
| 2020-09-30 |
$-10.00 |
| 2020-06-30 |
$0.00 |
| 2020-03-31 |
$-10.00 |
| 2019-12-31 |
$-215.00 |
| 2019-09-30 |
$-10.00 |
| 2019-06-30 |
$-10.00 |
| 2019-03-31 |
$-5.00 |
| 2018-12-31 |
$-90.00 |
| 2018-09-30 |
$-20.00 |
| 2018-06-30 |
$-10.00 |
| 2018-03-31 |
$-5.00 |
| 2017-12-31 |
$-160.00 |
| 2017-09-30 |
$-25.00 |
| 2017-06-30 |
$-25.00 |
| 2017-03-31 |
$-10.00 |
| 2016-12-31 |
$-35.00 |
| 2016-09-30 |
$-20.00 |
| 2016-06-30 |
$-30.00 |
| 2016-03-31 |
$-20.00 |
| 2015-12-31 |
$-180.00 |
| 2015-09-30 |
$35.00 |
| 2015-06-30 |
$15.00 |
| 2015-03-31 |
$-45.00 |
| 2014-12-31 |
$-255.00 |
| 2014-09-30 |
$-75.00 |
| 2014-06-30 |
$-100.00 |
| 2014-03-31 |
$-25.00 |
| 2013-12-31 |
$-125.00 |
| 2013-09-30 |
$-25.00 |
| 2013-06-30 |
$-50.00 |
| 2013-03-31 |
$-30.00 |
| 2012-12-31 |
$-10.00 |
| 2012-09-30 |
$15.00 |
| 2012-06-30 |
$20.00 |
| 2012-03-31 |
$30.00 |
| 2011-12-31 |
$45.00 |
| 2011-09-30 |
$55.00 |
| 2011-06-30 |
$60.00 |
| 2011-03-31 |
$60.00 |
| 2010-12-31 |
$75.00 |
| 2010-09-30 |
$70.00 |
| 2010-06-30 |
$70.00 |
| 2010-03-31 |
$55.00 |
| 2009-12-31 |
$35.00 |
| 2009-09-30 |
$85.00 |
| 2009-06-30 |
$50.00 |
| 2009-03-31 |
$45.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.007B |
$0.005B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
